Bioxcel Therapeutics Inc Stock Ownership - Who owns Bioxcel Therapeutics?

Insider buying vs selling

Have Bioxcel Therapeutics Inc insiders been buying or selling?
Frank YoccaChief Scientific Officer2024-04-041,067$2.64
Vimal MehtaCEO and President2024-04-044,439$2.63
Vimal MehtaCEO and President2024-04-04829$2.62
Vincent OneillExecutive Vice President Chief of Product Development and Medical Officer2024-04-04165$2.62
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2024-04-041,012$2.64
Richard I. SteinhartChief Financial Officer2024-04-041,069$2.64
Matthew T. WileyCHIEF COMMERCIAL OFFICER2024-04-041,008$2.64
Vimal MehtaCEO and President2023-06-1630,000$0.41
Vimal MehtaCEO and President2023-06-16747$21.89
Vimal MehtaCEO and President2023-06-164,266$20.90

1 of 2

BTAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTAI insiders and whales buy or sell their stock.

BTAI Shareholders

What type of owners hold Bioxcel Therapeutics Inc stock?
Vimal Mehta84.00%25,685,814$65.50MInsider
Bioxcel Holdings Inc57.45%17,566,750$44.80MInsider
Krishnan Nandabalan55.91%17,094,500$43.59MInsider
Vipin Agarwal27.98%8,554,945$21.82MInsider
Rashmi Agarwal27.98%8,554,945$21.82MInsider
Indu R. Gupta27.96%8,550,396$21.80MInsider
Tarun K. Gupta27.96%8,550,396$21.80MInsider
Suganthi Balasubramanian27.96%8,547,750$21.80MInsider
Diwakar Jain27.95%8,547,300$21.80MInsider
Anita Jain27.95%8,547,300$21.80MInsider

1 of 3

BTAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTAI4.33%95.67%Net SellingNet Selling
PLX6.75%93.25%Net Buying
MCRB59.28%30.14%Net SellingNet Selling

Bioxcel Therapeutics Stock Ownership FAQ

Who owns Bioxcel Therapeutics?

Bioxcel Therapeutics (NASDAQ: BTAI) is owned by 30.48% institutional shareholders, 673.72% Bioxcel Therapeutics insiders, and 0.00% retail investors. Vimal Mehta is the largest individual Bioxcel Therapeutics shareholder, owning 25.69M shares representing 84.00% of the company. Vimal Mehta's Bioxcel Therapeutics shares are currently valued at $70.64M.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.